Allergies News and Research

Latest Allergies News and Research

Low-birth-weight babies at significantly greater risk for early respiratory symptoms

Through age 5, children born at full term with low birth weight show significantly greater risk for developing respiratory symptoms, including wheezing, coughing and pulmonary infections, according to a large longitudinal study on birth weight and development.

16 May 2007

Natural antibodies and tissue injury

Lack of blood flow to the intestines during surgery, to the heart during a heart attack or to the brain during a stroke can cause damage to the organ involved.

15 May 2007

Peanut allergies overstated

Despite hundreds of families being told their children have peanut allergies every year, many of the children may be able to eat peanuts safely, a study by the University of New South Wales (UNSW) and Sydney Children's Hospital has found.

15 May 2007

U.S. decline in the number of qualified allergists-immunologists

A growing shortage of allergists in the United States may soon impact the quality of patient care for asthma and other allergic diseases, according to a report published by the American College of Allergy, Asthma and Immunology (ACAAI).

15 May 2007

Breakthrough on cytomegalovirus transmission

Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced , and in some cases eliminated , through the use of antibodies to enhance the disease-fighting power of the immune system.

11 May 2007

Pros and cons of drinking farm milk

Drinking farm milk can protect children against asthma and hayfever, according to a study of nearly 15,000 children published in the May issue of Clinical and Experimental Allergy.

11 May 2007

Right medications essential for allergy control

Choosing the right medications is essential to gaining control over symptoms as allergy season comes into full bloom, allergy specialists at UT Southwestern Medical Center warn.

10 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

Synthetic colouring and preservatives linked to hyperactivity in kids

Following the results of new research by the Food Standards Agency in Britain, parents are being told to avoid artificial colours commonly found in sweets and soft drinks.

9 May 2007

Prenatal toxicity linked to immune dysfunctions in later life

A Cornell researcher and his wife have conducted the first comprehensive review of later-life diseases that develop in people who were exposed to environmental toxins or drugs either in the womb or as infants.

4 May 2007

New study on cat allergens and babies

The study published by Chih-Mei Chen et al. in the May edition of the distinguished Journal of Allergy and Clinical Immunology did not approve earlier papers, according to which contact with cat allergens during the first few months of a child's life has a protective effect.

4 May 2007

Novel respiratory antibiotic Cethromycin, shown to be effective against Anthrax

Advanced Life Sciences Holdings has announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection.

4 May 2007

Peramivir shows promise for H5N1 protection

The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children's Research Hospital.

2 May 2007

Fred Hutchinson Cancer Research Center establishes new vaccine and disease institute

Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer.

2 May 2007

Adalimumab shows potential for Crohn's disease

A study led by Mayo Clinic found that adalimumab (HUMIRA) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE) therapy.

2 May 2007

Early-life exposure to indoor fungal molecules can help build stronger immune systems

Maybe being a fussy housekeeper isn't such a good thing after all.

1 May 2007

Schering-Plough announces European approval of new formulations of AERIUS (Desloratadine)

European Commission approves AERIUS Tablets (2.5 mg and 5 mg) and AERIUS Oral Solution (0.5 mg per 1ml).

30 Apr 2007

Employers can blame hay fever for the loss of millions of hours of work productivity this spring

A new study of nearly 600 people with hay fever symptoms, including sneezing, watery eyes and runny and itchy noses, found that workers missed an hour of work per week during peak hay fever season.

27 Apr 2007

New searchable influenza gene database

A Medical College of Wisconsin and Children's Research Institute team in Milwaukee has created a free, searchable genetic database that will significantly improve diagnostic testing and genetic tracking of human and animal influenza viruses.

26 Apr 2007

Scientists discover new virus responsible for deaths of 3 transplant recipients

Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.

24 Apr 2007